While airlines frequently receive criticism, it is also important to acknowledge their positive actions. Appreciate the help extended by Ms Keertana from Air India at Bengaluru airport today for a baggage issue which otherwise cud have cost me my laptop.
@airindia
@reliancejio@JioCare
Dear Jio: It’s been a long wait for my refund. the helpline numbers and the website are of no help. That is why I am writing on X. Surprisingly your executives on X have also stopped responding. Customer service is so bad.
@JioCare I have been struggling for my refund after I ported my connection to Airtel. Have tried numerous times but there is no resolution. One of the worst after sales services I have seen is by Jio.
The agents keep asking about the issue again and again but no resolution.
@reliancejio Dear Jio. Claiming a refund from Jio after termination of my jio connection is turning out to be a pain. The help centre is not able to help, tried numerous times. Tell me what to do !!
@BofA_Help
Hello. I am a customer of Bank of America. I was in the US to pursue my studies and have come back to India. I need to urgently connect with BofA through an email since I tried calling the customer care helpline from India numerous times but it dint help. ITS URGENT
There are very few African pharma manufacturers that apply for the Medicines Patent Pool expressions of interest to receive licenses. MPP is considering having Africa-specific calls, which may include offering licenses conditionally. https://t.co/y3rfxOAh7Z
ICMR congratulates @iitbombay and @TataMemorial for launching India’s 1st home-grown gene therapy for cancer! 🇮🇳 Accessible & affordable CAR-T cell therapy offers new hope for all of humanity. A landmark moment in medical science! #MakeInIndia#MedicalBreakthrough
.@Gavi, the Vaccine Alliance, is months away from launching a new instrument that will provide up to $1 billion to boost Africa’s vaccine manufacturing sector. I spoke with David Kinder, director of development finance, to learn about how it will work: https://t.co/6E8QBfkaw7
#SingleWindowToIndia: Strengthening the ease of doing business!
One stop for all global companies to establish their presence in India
🎥 #WATCH this video to know how the National Single Window System Portal is ensuring ease of doing business 👇
#9YearsOfSeva@DoC_GoI
Day 3 of #G20India 3rd HWG meeting drew to a successful close today.
The delegates visited India's state-of-the-art research facilities at Genome Valley, NARFBR of Indian Council of Medical Research and Bharat Biotech, and the day continued with some enlightening presentations and meaningful discussions on the need to enhance global collaboration on R&D.
Glimpses!
@PMOIndia@mansukhmandviya@DrBharatippawar@spsinghbaghelpr@g20org@PIB_India
#G20India | At 3rd meeting of G20 Health Working Group, Hyderabad, delegates visited @BharatBiotech's Genome Valley plant
During the visit, Delegates understood and observed how vaccines are made
Bharat Biotech produced country's first indigenous vaccine for #COVID19@g20org
#G20India | Enormous praise for India for the way they have hosted G20 Presidency despite complications around the world like #COVID19, says @WHO Chief Scientist, Sir Jeremy Farrar
@g20org
In her opening remark at the inaugural session of the side event of the #G20India 3rd HWG meeting on 'Strengthening Global Collaboration Network on Research and Development in Medical Countermeasures', Ms. S Aparna, Secretary, Department of Pharmaceuticals, highlighted the importance of R&D in Medical Counter Measures with a focus on future health emergencies. She noted that a comprehensive and coordinated approach towards R&D in Vaccines, Therapeutics, and Diagnostics provides a framework to address complex challenges that we face.
She underscored that "priorities and optimization are important as we explore opportunities of R&D in Vaccines Therapeutics and Diagnostics within the MCM framework".
@PMOIndia@g20org
Our mission is to deliver affordable, safe, and high-quality vaccines and bio-therapeutics that help people prevail over diseases. We seek to lead innovation in biotechnology in order to lead the fight against disease with a focus on emerging markets: Dr Krishna Ella, Chairman, Bharat Biotech at the panel discussion on 'Emerging needs and potential benefits for Global collaboration on R&D of VTDs for Prevention, Preparedness, Response'.
#G20India
@PMOIndia@g20org
Sir Jeremy J. Farrar, Chief Scientist, @WHO, highlighted the importance of partnerships as a crucial driver of health emergency response mechanism at the panel discussion of the 3rd HWG meeting on 'Emerging needs and potential benefits for Global collaboration on R&D of VTDs for Prevention, Preparedness, Response.
He said, "We acknowledge the structural, deep, and long-standing inequity of access to vaccines and diagnostics in healthcare. Equitable access to research and fruits of innovation will need long-term public and private investment in scientific basic infrastructure".
@PMOIndia@g20org
#G20India | Day 3 of the 3rd Health Working Group Meeting, Hyderabad.
Today, the delegates will visit National Animal Resource Facility for Biomedical Research (NARFBR) and Indian Council of Medical Research (ICMR) / Bharat Biotech facilities at Genome Valley and will engage in a session on building global R&D network.
@PMOIndia@g20org
It is terrific that India has called for creation of network to support medical counter measures development. I am very supportive of the efforts to advance digital health and create common effort among the G20 countries to advance digital health tools : Dr. Richard J Hatchett, CEO, @CEPIvaccines
#G20IndiaHealthyTalks
@PMOIndia@mansukhmandviya@DrBharatippawar@spsinghbaghelpr@g20org@PIB_India